BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28267891)

  • 1. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
    Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro anti-tuberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,2,3-triazole derivatives.
    Sajja Y; Vanguru S; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5119-5121. PubMed ID: 29113761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial activity of substituted isosteres of pyridine- and pyrazinecarboxylic acids. 2.
    Gezginci MH; Martin AR; Franzblau SG
    J Med Chem; 2001 May; 44(10):1560-3. PubMed ID: 11334565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
    Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
    Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
    Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in silico study of pyridine based 1,3,4-oxadiazole embedded hydrazinecarbothioamide derivatives as potent anti-tubercular agent.
    Ambhore AN; Kamble SS; Kadam SN; Kamble RD; Hebade MJ; Hese SV; Gaikwad MV; Meshram RJ; Gacche RN; Dawane BS
    Comput Biol Chem; 2019 Jun; 80():54-65. PubMed ID: 30901601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
    Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
    Zampieri D; Mamolo MG; Laurini E; Fermeglia M; Posocco P; Pricl S; Banfi E; Scialino G; Vio L
    Bioorg Med Chem; 2009 Jul; 17(13):4693-707. PubMed ID: 19467603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
    Shruthi TG; Eswaran S; Shivarudraiah P; Narayanan S; Subramanian S
    Bioorg Med Chem Lett; 2019 Jan; 29(1):97-102. PubMed ID: 30448235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines.
    Navarrete-Vázquez G; Molina-Salinas GM; Duarte-Fajardo ZV; Vargas-Villarreal J; Estrada-Soto S; González-Salazar F; Hernández-Núñez E; Said-Fernández S
    Bioorg Med Chem; 2007 Aug; 15(16):5502-8. PubMed ID: 17562368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
    Fernandes GFDS; de Souza PC; Marino LB; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Chung MC; Pavan FR; Dos Santos JL
    Eur J Med Chem; 2016 Nov; 123():523-531. PubMed ID: 27508879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel class of quinoline-oxadiazole hybrids as anti-tuberculosis agents.
    Jain PP; Degani MS; Raju A; Anantram A; Seervi M; Sathaye S; Ray M; Rajan MGR
    Bioorg Med Chem Lett; 2016 Jan; 26(2):645-649. PubMed ID: 26675440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
    Roh J; Karabanovich G; Vlčková H; Carazo A; Němeček J; Sychra P; Valášková L; Pavliš O; Stolaříková J; Klimešová V; Vávrová K; Pávek P; Hrabálek A
    Bioorg Med Chem; 2017 Oct; 25(20):5468-5476. PubMed ID: 28835350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
    Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
    Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives.
    Kasimogullari BO; Cesur Z
    Molecules; 2004 Sep; 9(10):894-901. PubMed ID: 18007490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
    Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
    Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.